Millennium Management LLC Has $19.27 Million Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Millennium Management LLC grew its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 4,757.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,622,022 shares of the construction company's stock after acquiring an additional 1,588,632 shares during the quarter. Millennium Management LLC owned 1.98% of Aspen Aerogels worth $19,270,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Aspen Aerogels by 9.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,040 shares of the construction company's stock worth $416,000 after acquiring an additional 3,041 shares during the last quarter. LMR Partners LLP acquired a new position in Aspen Aerogels during the 4th quarter worth approximately $1,684,000. Graham Capital Management L.P. boosted its position in Aspen Aerogels by 107.7% during the 4th quarter. Graham Capital Management L.P. now owns 131,475 shares of the construction company's stock worth $1,562,000 after acquiring an additional 68,177 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Aspen Aerogels by 37.0% during the 4th quarter. Deutsche Bank AG now owns 415,391 shares of the construction company's stock worth $4,935,000 after purchasing an additional 112,241 shares in the last quarter. Finally, Corton Capital Inc. bought a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $348,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Down 4.3%

ASPN opened at $6.08 on Thursday. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The stock's fifty day simple moving average is $5.83 and its 200 day simple moving average is $9.89. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market cap of $498.79 million, a PE ratio of 37.97 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to analysts' expectations of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm's revenue for the quarter was down 16.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.02) EPS. As a group, research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of analyst reports. Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Barclays dropped their price objective on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. Roth Mkm dropped their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Finally, B. Riley dropped their price objective on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.11.

Insiders Place Their Bets

In other news, CEO Donald R. Young acquired 20,000 shares of the stock in a transaction on Monday, May 12th. The shares were purchased at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the transaction, the chief executive officer now directly owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 4.30% of the company's stock.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.